Mitochondrial ribosome protein S11 (MRPS11) and mitochondrial serine hydroxymethyltransferase2 (SHMT2) were identified as significant biomarkers for MDD, with markedly reduced expression in patient samples. This evidence concerns the gene MRPS11 and major depressive disorder.